PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15517883-5	2004	Potential PPAR gamma agonists and antagonists inhibited the incorporation of thymidine into DNA of human prostate (PC3), colon (Caco-2) and breast (T47D) cancer cells but also affected NIH3T3 cells that have little or no expression of PPAR gamma.	Thymidine	77-86	peroxisome proliferator activated receptor gamma	Homo sapiens	10-20	
14581151-7	2003	PPARgamma-overexpression or troglitazone treatment alone reduced the thymidine uptake by the HUVEC with or without TNFalpha treatment.	Thymidine	69-78	peroxisome proliferator activated receptor gamma	Homo sapiens	0-9	
14581151-8	2003	There was a further decrease in the thymidine uptake with troglitazone treatment in the PPARgamma-overexpressed HUVEC.	Thymidine	36-45	peroxisome proliferator activated receptor gamma	Homo sapiens	88-97	
10935488-5	1999	Treatment of the T24 bladder cancer cells with the TZD PPARgamma agonist troglitazone, dramatically inhibited 3H-thymidine incorporation and induced cell death.	Thymidine	113-122	peroxisome proliferator activated receptor gamma	Homo sapiens	55-64	
11777901-4	2002	PPAR-gamma ligands 15-deoxy-Delta(12,14)-prostaglandin J(2) and troglitazone reduced TXR mRNA expression levels as well as cell growth as assessed by [(3)H]thymidine incorporation.	Thymidine	156-165	peroxisome proliferator activated receptor gamma	Homo sapiens	0-10	
16179407-8	2006	In this model, PAX8-PPARgamma expression was associated with enhanced growth as assessed by soft agar assays and thymidine uptake.	Thymidine	113-122	peroxisome proliferator activated receptor gamma	Homo sapiens	20-29